You are here: Industry Insights > Sinovac

News List

Sinovac Announces Approval of Varicella Vaccine for Chickenpox in China americanpharmaceuticalreview
January 07, 2020
Sinovac Biotech announced the China National Medical Products Administration (NMPA) has approved and issued a Product license for the Company’s varicella vaccine to prevent the varicella-zoster virus in children from 1 to 12 years old.
Sinovac Determines Trigger Event Occurred Under Rights Agreement firstwordpharma
February 24, 2019
Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China.
Accusing OrbiMed as co-conspirator in failed coup, Sinovac aborts go-private deal fiercevaccines
July 23, 2018
In a string of bizarre events that involve violence, lawsuits and a high-profile investment shop, Nasdaq-listed Chinese vaccine maker Sinovac has terminated its plan to take the company private.
Sinovac Announces Preliminary Results of Phase III Trial on sIPV biospace
April 20, 2018
Sinovac Biotech Ltd. today announced preliminary results of a phase III clinical study on Sabin inactivated polio vaccine ("sIPV") developed by Sinovac Biotech Co., Ltd. ("Sinovac Beijing") on the unblinding conference held on April 19, 2018.
Sinovac Enters into Amendment to Amalgamation Agreement for Going-Private Transaction prnasia
March 28, 2018
Sinovac Biotech Ltd. today announced that on March 26, 2018
Sinovac Sets the Record Straight Regarding False Statements by Unauthorized Third Parties prnasia
March 16, 2018
Sinovac Biotech Ltd. today responded to public statements made by other parties falsely claiming to control the Company, including a press release falsely purporting to come from Sinovac itself.
Sinovac Newly-Elected Board of Directors' Response to the Announcement of the Purported Re-Election prnasia
March 15, 2018
Four new board members were elected at the February 6, 2018 Annual Meeting of Shareholders.
Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq prnasia
November 06, 2017
Sinovac Biotech Ltd. (Nasdaq: SVA) ("Sinovac"), a leading provider of biopharmaceutical products in China, announced today that on November 1, 2017
To Fight Against The Behavior Between Sinovac's Special Committee And Weidong Yin's Consortium And T en-cphi.cn
June 29, 2017
On the evening of June 26, 2017 Beijing time, Sinovac Biotech Ltd. (Nasdaq: SVA, "Sinovac") announced that Sinovac entered into a Definitive Agreement ("Amalgamation Agreement") for Going-Private Transaction with Weidong Yin's consortium ("Consortium A")

Previous page 1 2 3 Next page